Sofie Denies
Impact in
- Biological Psychiatry top 10%
- Tryptophan and brain disorders
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
-
- Immunotherapy and Immune Responses 6
- Oncology 5
- Cancer Immunotherapy and Biomarkers 3
- Cancer Cells and Metastasis 1
- Co-authors
- Niek N. Sanders (10 shared papers)Chloé Ackaert (2 shared papers)Yann G.‐J. Sterckx (1 shared paper)Benoı̂t Stijlemans (1 shared paper)Karine Breckpot (1 shared paper)Nick Devoogdt (1 shared paper)Serge Muyldermans (1 shared paper)Yvon Elkrim (1 shared paper)
- Journals
- Molecular Cancer Therapeutics (2 papers)Veterinary and Comparative Oncology (2 papers)Journal for ImmunoTherapy of Cancer (1 paper)Frontiers in Immunology (1 paper)Expert Review of Vaccines (1 paper)
- Partner nations
- BelgiumUnited StatesFrance
In The Last Decade
Sofie Denies
15 papers receiving 475 citations
Sofie Denies's Hit Papers
Peers
Comparison fields: 5 of 49
- Biological Psychiatry 22
- Oncology 149
- Radiology, Nuclear Medicine and Imaging 115
- Immunology 101
- Biotechnology 19
Countries citing papers authored by Sofie Denies
This map shows the geographic impact of Sofie Denies's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofie Denies with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofie Denies more than expected).
Fields of papers citing papers by Sofie Denies
This network shows the impact of papers produced by Sofie Denies. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofie Denies. The network helps show where Sofie Denies may publish in the future.
Co-authors
The 25 scholars most cited alongside Sofie Denies, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Immunogenicity Risk Profile of Nanobodies Hit paper breakdown → | 2021 | 175 |
| 2 | 2018 | 74 | |
| 3 | 2020 | 59 | |
| 4 | 2016 | 31 | |
| 5 | 2014 | 29 | |
| 6 | 2016 | 20 | |
| 7 | 2016 | 19 | |
| 8 | 2016 | 17 | |
| 9 | 2012 | 16 | |
| 10 | 2016 | 12 | |
| 11 | 2016 | 12 | |
| 12 | 2016 | 7 | |
| 13 | 2015 | 6 | |
| 14 | 2024 | 4 | |
| 15 | 2017 | 3 |
About Sofie Denies
Sofie Denies is a scholar working on Immunology, Oncology, Pulmonary and Respiratory Medicine, Biotechnology and Cancer Research, having authored 15 papers that have together received 484 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (6 papers), Veterinary Oncology Research (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Angiogenesis and VEGF in Cancer (2 papers), Breast Lesions and Carcinomas (1 paper), RNA Interference and Gene Delivery (1 paper), Cancer Cells and Metastasis (1 paper) and Monoclonal and Polyclonal Antibodies Research (1 paper). The work is most often cited by research in Biological Psychiatry (22 citations), Oncology (149 citations), Radiology, Nuclear Medicine and Imaging (115 citations), Immunology (101 citations) and Biotechnology (19 citations). Sofie Denies has collaborated with scholars based in Belgium, United States and France. Frequent co-authors include Niek N. Sanders, Chloé Ackaert, Yann G.‐J. Sterckx, Benoı̂t Stijlemans, Karine Breckpot, Nick Devoogdt, Serge Muyldermans, Yvon Elkrim, Catarina Xavier and Marleen Keyaerts. Their work appears in journals such as Molecular Cancer Therapeutics, Veterinary and Comparative Oncology, Journal for ImmunoTherapy of Cancer, Frontiers in Immunology and Expert Review of Vaccines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.